2-111778685-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP2
The NM_022662.4(ANAPC1):c.5375C>A(p.Ala1792Glu) variant causes a missense change involving the alteration of a conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 14)
Exomes 𝑓: 0.000014 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ANAPC1
NM_022662.4 missense
NM_022662.4 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 9.28
Genes affected
ANAPC1 (HGNC:19988): (anaphase promoting complex subunit 1) This gene encodes a subunit of the anaphase-promoting complex. This complex is an E3 ubiquitin ligase that regulates progression through the metaphase to anaphase portion of the cell cycle by ubiquitinating proteins which targets them for degradation. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ANAPC1. . Gene score misZ 0.98694 (greater than the threshold 3.09). Trascript score misZ 5.2521 (greater than threshold 3.09). GenCC has associacion of gene with Rothmund-Thomson syndrome type 1.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC1 | NM_022662.4 | c.5375C>A | p.Ala1792Glu | missense_variant | 45/48 | ENST00000341068.8 | NP_073153.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC1 | ENST00000341068.8 | c.5375C>A | p.Ala1792Glu | missense_variant | 45/48 | 1 | NM_022662.4 | ENSP00000339109.3 | ||
ANAPC1 | ENST00000427997.5 | c.3977C>A | p.Ala1326Glu | missense_variant | 34/37 | 1 | ENSP00000396695.1 | |||
ANAPC1 | ENST00000462785.1 | n.2069C>A | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
ANAPC1 | ENST00000643447.1 | n.401C>A | non_coding_transcript_exon_variant | 5/12 | ENSP00000494863.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 117670Hom.: 0 Cov.: 14 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
117670
Hom.:
Cov.:
14
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000148 AC: 3AN: 202458Hom.: 0 AF XY: 0.00000908 AC XY: 1AN XY: 110086
GnomAD3 exomes
AF:
AC:
3
AN:
202458
Hom.:
AF XY:
AC XY:
1
AN XY:
110086
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000136 AC: 18AN: 1326742Hom.: 0 Cov.: 19 AF XY: 0.0000105 AC XY: 7AN XY: 666530
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
18
AN:
1326742
Hom.:
Cov.:
19
AF XY:
AC XY:
7
AN XY:
666530
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 117670Hom.: 0 Cov.: 14 AF XY: 0.00 AC XY: 0AN XY: 55352
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
117670
Hom.:
Cov.:
14
AF XY:
AC XY:
0
AN XY:
55352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The c.5375C>A (p.A1792E) alteration is located in exon 45 (coding exon 44) of the ANAPC1 gene. This alteration results from a C to A substitution at nucleotide position 5375, causing the alanine (A) at amino acid position 1792 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Loss of MoRF binding (P = 0.0777);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at